Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
11
2020
FDA and FTC Issue Warning Letters to Companies Selling Fraudulent Products to Treat or Prevent COVID-19 Keller and Heckman LLP
Mar
11
2020
Gin Manufacturer Bacardi Avoids Lawsuit for Its Use of “Grains of Paradise” Proskauer Rose LLP
Mar
11
2020
Coming Soon to the Southeast? A Summary of Medical Marijuana Legalization Efforts in Alabama, Kentucky, and Mississippi Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
10
2020
FDA and FTC Warn Companies for Unauthorized Coronavirus Disease 2019 (COVID-19) Claims Greenberg Traurig, LLP
Mar
10
2020
The Long Reach of Proposition 65 Vedder Price
Mar
10
2020
FDA and FTC Warn Dietary Supplement Manufacturers Against Making Fraudulent Anti-Coronavirus Claims Beveridge & Diamond PC
Mar
10
2020
SCCS Guidance on Safety Assessment of Nanomaterials in Cosmetics Published in Regulatory Toxicology and Pharmacology Bergeson & Campbell, P.C.
Mar
10
2020
Prop 65 Warnings and Acrylamide in Food – Can I Still Have My Coffee and Drink it Too? Sheppard, Mullin, Richter & Hampton LLP
Mar
10
2020
CBD Manufacturers and Retailers Face Action from the FDA and Consumer Litigants ArentFox Schiff LLP
Mar
10
2020
Health Canada Requests Data to Modify the Lists of Permitted Food Additives for Certain Food Flavoring Preparations Keller and Heckman LLP
Mar
10
2020
California Enacts New Warning Requirements Applicable to Cannabis and CBD Products Foley & Lardner LLP
Mar
10
2020
Collaborative Review of Scientific Evidence Announced By FDA Foley & Lardner LLP
Mar
9
2020
EPA Expediting Emerging Viral Pathogens Claim Submissions Bergeson & Campbell, P.C.
Mar
9
2020
FDA Provides Congressionally-Mandated Cannabidiol (CBD) Report but Reveals Little Progress Keller and Heckman LLP
Mar
9
2020
EPA Releases Supplemental Proposed Rule to the Proposed Rule on Strengthening Transparency in Regulatory Science Bergeson & Campbell, P.C.
Mar
9
2020
Florida Federal District Court Rules GRAS Regulation Preempts Florida Statute Criminalizing Ingredient McDermott Will & Emery
Mar
7
2020
Mississippi Supreme Court Rejects ‘Passage of Title’ DTC Theory McDermott Will & Emery
Mar
7
2020
FDA Launches New “Feed Your Mind” Initiative to Increase Consumer Understanding of Genetically Engineered Foods Keller and Heckman LLP
Mar
6
2020
First DOJ Enforcement under New Opioids Kickback Law Announced Dinsmore & Shohl LLP
Mar
6
2020
Can the DOJ Really Prosecute State-Legal Marijuana Entities? Dinsmore & Shohl LLP
Mar
6
2020
Managing the Commercial Impact of the Coronavirus: Food & Beverage Foley & Lardner LLP
Mar
6
2020
EPA Releases List of Disinfectants for Use against COVID-19 Bergeson & Campbell, P.C.
Mar
5
2020
Clinical Trial Results Will See Daylight After HHS Final Rule Is Set Aside Mintz
Mar
5
2020
Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison Fulton [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Mar
5
2020
Antitrust Liability Risk When Listing Patents in Orange Book McDermott Will & Emery
Mar
5
2020
How FDA is Reacting to the Coronavirus, and 2020 Regulatory Priorities Sheppard, Mullin, Richter & Hampton LLP
Mar
5
2020
Dairy Industry Urges FDA to Prohibit the Use of Traditional Dairy Terms on Plant-Based Products Keller and Heckman LLP
Mar
5
2020
Comments on Proposed Supplemental SNUR on LCPFAC Chemical Substances Due April 17 Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins